Nyrada Inc. (ASX: NYR)
Health Care · Pharmaceuticals · AU
AU$0.48
-7.69% today · +37.1% 1Y
Nyrada Inc. (ASX: NYR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $82.93M and employs 4,000 people.
Over the last twelve months the share price has gained 37.1%, trading between 0.31 and 1.44.
Tweenvest scores Nyrada Inc. across four factors: quality 35/100, value 63/100, growth 0/100. Its strongest factor is value.
NYR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $82.93M
- Revenue (TTM)
- $1.39M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- 1.03
- 52-week high
- AU$1.44
- 52-week low
- AU$0.31
- Avg volume (3M)
- —
- Shares outstanding
- 247.59M
- Employees
- 4,000
- Next earnings
- —
About Nyrada Inc.
Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases. Its lead candidate is Xolatryp, a small molecule drug which has completed phase 1 clinical trial for neuroprotection and cardioprotection indications and in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.
- ISIN
- AU0000070195
- Founded
- 2017
- Listed since
- Jan 15, 2020
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ZIM Laboratories LimitedBSE: 541400 | $83.55M | Rs150.70 | +10.44% |
| Cognition Therapeutics, Inc.NasdaqCM: CGTX | $83.39M | $0.86 | -2.28% |
| Rafael Holdings, Inc.NYSE: RFL | $83.20M | $1.50 | -6.25% |
| HANDOK Inc.KOSE: A002390 | $83.10M | ₩8,600.00 | +0.47% |
| Euroapi S.A.ENXTPA: EAPI | $82.58M | €0.77 | 0.00% |
| Telomir Pharmaceuticals, Inc.NasdaqCM: TELO | $82.45M | $1.13 | +0.89% |
| Zhengye Biotechnology Holding LimitedNasdaqCM: ZYBT | $81.99M | $1.64 | -5.20% |
| Zhongzhi Pharmaceutical Holdings LimitedSEHK: 3737 | $80.88M | HK$0.74 | -2.65% |
Figures last refreshed Oct 11, 2026.